{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:50:25Z","timestamp":1791049825944,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.jocn.2009.09.034","type":"journal-article","created":{"date-parts":[[2010,3,31]],"date-time":"2010-03-31T04:42:48Z","timestamp":1270010568000},"page":"717-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson\u2019s disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Chiaki","family":"Isobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Terayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2009.09.034_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1590\/S1413-81232008000100030","article-title":"Environmental exposures and gene regulation in disease etiology","volume":"13","author":"Edwards","year":"2008","journal-title":"Cien Saude Colet"},{"key":"10.1016\/j.jocn.2009.09.034_bib2","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI116712","article-title":"Homocysteine, a thrombogenic agent, suppresses anticoagulant heparin sulfate expression in cultured porcine aortic endothelial cells","volume":"92","author":"Nishinaga","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocn.2009.09.034_bib3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI112442","article-title":"Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine","volume":"77","author":"Starkebaum","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocn.2009.09.034_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/clinchem\/41.3.340","article-title":"Homocysteine species as components of plasma redox thiol status","volume":"41","author":"Ueland","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.jocn.2009.09.034_bib5","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2009.09.034_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylentetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocn.2009.09.034_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/gerona\/52A.2.M76","article-title":"Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer\u2019s disease?","volume":"252","author":"Joosten","year":"1997","journal-title":"J Gerontol"},{"key":"10.1016\/j.jocn.2009.09.034_bib8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1995.03530190040032","article-title":"Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study","volume":"274","author":"Nygard","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2009.09.034_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000017092","article-title":"Identification of cognitive impairment in the elderly: homocysteine is an early marker","volume":"10","author":"Lehmann","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jocn.2009.09.034_bib10","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1523\/JNEUROSCI.22-05-01752.2002","article-title":"Folic acid deficiency and homocysteine impair DNA in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer\u2019s disease","volume":"22","author":"Kruman","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.jocn.2009.09.034_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1468-1331.2006.01207.x","article-title":"Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson\u2019s disease","volume":"13","author":"Isobe","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2009.09.034_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2009.09.034_bib13","first-page":"527","article-title":"Sulphate and cysteine levels in the plasma of patients with Parkinson\u2019s disease","volume":"16","author":"Allain","year":"1995","journal-title":"Neurotoxicol"},{"key":"10.1016\/j.jocn.2009.09.034_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s004150050292","article-title":"Hyperhomocysteinaemia in Parkinson\u2019s disease","volume":"32","author":"Kuhn","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2009.09.034_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(99)01660-8","article-title":"Nigral endothelial dysfunction, homocysteine, and Parkinson\u2019s disease","volume":"354","author":"M\u00fcller","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2009.09.034_bib16","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/mds.21020","article-title":"Iron metabolism in Parkinsonian syndromes","volume":"21","author":"Berg","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2009.09.034_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jcb.21982","article-title":"Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS\/CBS double knockout mice","volume":"106","author":"Kundu","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jocn.2009.09.034_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","article-title":"Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson\u2019s disease","volume":"80","author":"Wenzhem","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2009.09.034_bib19","doi-asserted-by":"crossref","unstructured":"Yasui K, Kowa H, Nakaso K, et al. Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD. Neurology 2000;55:437\u201340.","DOI":"10.1212\/WNL.55.3.437"},{"key":"10.1016\/j.jocn.2009.09.034_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-0270(96)00002-7","article-title":"Standardized methods to bioassay neurotrophic factors for dopaminergic neurons","volume":"67","author":"Takeshima","year":"1996","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jocn.2009.09.034_bib21","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.lfs.2005.02.014","article-title":"Increased of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"77","author":"Isobe","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.jocn.2009.09.034_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exnr.2001.7726","article-title":"L-dopa upregulates the expression and activities of methionine adenosyl-transferase and catechol-O-methyltransferase","volume":"171","author":"Zhao","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jocn.2009.09.034_bib23","first-page":"241","article-title":"Role of homocysteine in age-related vascular and non-vascular disease","volume":"9","author":"Parnetti","year":"1997","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.jocn.2009.09.034_bib24","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1523\/JNEUROSCI.14-07-04385.1994","article-title":"Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione","volume":"14","author":"Rantan","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.jocn.2009.09.034_bib25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","article-title":"Blood vessels change in the mesencephalon of patients with Parkinson\u2019s disease","volume":"353","author":"Faucheux","year":"1999","journal-title":"Lancet"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586809007127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586809007127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:12:27Z","timestamp":1760821947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586809007127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0967586809007127"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2009.09.034","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2009.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}